1. Home
  2. Labeler Index
  3. Takeda Pharmaceuticals America, Inc.
  4. 64764-158
  5. NDC Package Code: 64764-158-41 Actoplus Met

NDC Package 64764-158-41 Actoplus Met

Pioglitazone And Metformin Hydrochloride Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
64764-158-41
Package Description:
4 CARTON in 1 TRAY / 1 BLISTER PACK in 1 CARTON / 7 TABLET, FILM COATED in 1 BLISTER PACK
Product Code:
64764-158
Proprietary Name:
Actoplus Met
Non-Proprietary Name:
Pioglitazone And Metformin Hydrochloride
Substance Name:
Metformin Hydrochloride; Pioglitazone Hydrochloride
Usage Information:
This combination medication is used along with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone belongs to a class of drugs known as thiazolidinediones or "glitazones". Metformin and pioglitazone work by helping to restore your body's proper response to the insulin you naturally produce. Metformin also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. Talk to your doctor about the risks and benefits of using pioglitazone-containing products.
11-Digit NDC Billing Format:
64764015841
NDC to RxNorm Crosswalk:
  • RxCUI: 861822 - pioglitazone 15 MG / metFORMIN HCl 850 MG Oral Tablet
  • RxCUI: 861822 - metformin hydrochloride 850 MG / pioglitazone 15 MG Oral Tablet
  • RxCUI: 861822 - metformin HCl 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 MG Oral Tablet
  • RxCUI: 861824 - actoplus met 15 MG / 850 MG Oral Tablet
  • RxCUI: 861824 - metformin hydrochloride 850 MG / pioglitazone 15 MG Oral Tablet [Actoplus Met]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Takeda Pharmaceuticals America, Inc.
    Dosage Form:
    Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • METFORMIN HYDROCHLORIDE 850 mg/1
  • PIOGLITAZONE HYDROCHLORIDE 15 mg/1
    • Pharmacologic Class(es):
  • Biguanide - [EPC] (Established Pharmacologic Class)
  • Biguanides - [CS]
  • Peroxisome Proliferator Receptor alpha Agonist - [EPC] (Established Pharmacologic Class)
  • Peroxisome Proliferator Receptor gamma Agonist - [EPC] (Established Pharmacologic Class)
  • Peroxisome Proliferator-activated Receptor alpha Agonists - [MoA] (Mechanism of Action)
  • Peroxisome Proliferator-activated Receptor gamma Agonists - [MoA] (Mechanism of Action)
  • Thiazolidinedione - [EPC] (Established Pharmacologic Class)
  • Thiazolidinediones - [CS]
    • Sample Package:
    No
    FDA Application Number:
    NDA021842
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    08-29-2005
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    64764-158-18180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
    64764-158-6060 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 64764-158-41?

    The NDC Packaged Code 64764-158-41 is assigned to a package of 4 carton in 1 tray / 1 blister pack in 1 carton / 7 tablet, film coated in 1 blister pack of Actoplus Met, a human prescription drug labeled by Takeda Pharmaceuticals America, Inc.. The product's dosage form is tablet, film coated and is administered via oral form.

    Is NDC 64764-158 included in the NDC Directory?

    Yes, Actoplus Met with product code 64764-158 is active and included in the NDC Directory. The product was first marketed by Takeda Pharmaceuticals America, Inc. on August 29, 2005 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 64764-158-41?

    The 11-digit format is 64764015841. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-264764-158-415-4-264764-0158-41